Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)

Delayed Data
As of Dec 02
 +1.26 / +4.67%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 35.00, with a high estimate of 40.00 and a low estimate of 25.00. The median estimate represents a +23.85% increase from the last price of 28.26.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.96%
Growthannually -155.63%


Growthquarterly 69.27%
Growthannually 587.71%
Key to the earnings and sales forecast charts.